Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 5
Review
Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 27,243 | Dovepress* | 14,443+ | 3,845 | 18,288 | |
| PubMed Central* | 12,800 | 2,787 | 15,587 | ||
| Totals | 27,243 | 6,632 | 33,875 | ||
|
*Since 23 July 2012 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 0 | 4 |
View citations on PubMed Central and Google Scholar